This is a $1,300,000.00 Firm Fixed Price definitive contract awarded by the Defense Health Agency (DHA) to Critical Innovations LLC, a small business, for the SBIR Phase II effort titled "Succor Combat Foam for Large Burn Wounds". The contract supports research and development of a specialized foam solution for treating large burn wounds, which is a critical capability for the military. Critical Innovations has been awarded over $10 million in previous prime federal contracts across...
This is a $250,000.00 Firm Fixed Price purchase order awarded to Critical Innovations LLC, a small business, by the Defense Health Agency (DHA) under the Small Business Innovation Research (SBIR) program. The contract is for Phase I research and development of the "Succor Combat Foam for Open Traumatic Brain Injury Medical R&D" topic. This SBIR award is a total small business set-aside, indicating Critical Innovations is the prime contractor without any major subcontractors. The...
This is a $1,550,000.00 fixed-price level of effort contract awarded by the Defense Health Agency (DHA) to Critical Innovations LLC, a small business limited liability company. The contract is for the Small Business Innovation Research (SBIR) Phase II project "DHA SBIR PHASE II O2-1681" and has a completion date of December 3, 2021. The contract is designated as a total small business set-aside. Critical Innovations, an ISO 13485:2016 certified medical research and development company,...
The U.S. Army's Joint PEO Chemical and Biological Defense has awarded a $1,099,999.92 Firm Fixed Price contract to Critical Innovations LLC, a small business medical research and development company, for Phase II of a Small Business Innovation Research (SBIR) program effort. The contract is designated as a total small business set-aside. Critical Innovations will continue development of various advanced medical technologies for military and pre-hospital applications, including solutions for...
This is a $150,000.00 Firm Fixed Price contract awarded by the Department of the Army Medical Command to Critical Innovations LLC, a small business limited liability company, under the Small Business Innovation Research (SBIR) program. The contract is for Phase I research and development of a "Nanostasis Intravenous Agent for Traumatic Hemorrhage Control". Critical Innovations is an ISO certified and DCAA compliant medical research and development company that has been awarded over $10...
This is a $150,000.00 Firm Fixed Price Definitive Contract awarded by the U.S. Army Medical Command (MEDCOM) to Critical Innovations LLC, a small business located in Lawndale, California. The contract is for a Small Business Innovation Research (SBIR) Phase I effort, which is a research and development task focused on innovative solutions for military and pre-hospital healthcare applications. The contract has a period of performance ending on April 24, 2018 and is designated as a total small...
The Department of the Army awarded a $167,499.96 firm-fixed-price Phase I Small Business Innovation Research (SBIR) program contract to Critical Innovations LLC, a limited liability company, for research and development efforts to develop treatments for dermal injuries caused by sulfur mustard. The contract has a total small business set-aside designation. Critical Innovations has previously received over $10 million in SBIR contracts from the Army, Defense Health Agency, and Air Force for...
This is a $150,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Medical Command (MEDCOM) to Critical Innovations LLC, a small business medical research and development company. The contract is for the SBIR DHP PHASE I PROPOSAL H161-011-0011, which involves the development of innovative solutions for military and pre-hospital healthcare applications. Critical Innovations specializes in advanced medical technologies such as wound treatment, hemorrhage...
This is a $946,809.00 Firm Fixed Price Definitive Contract awarded by the Department of the Army Medical Command to Critical Innovations LLC, a for-profit limited liability company. The contract is for the Pleurapath Chest Tube Augmentation and Acceleration Program under the Joint Warfighter Medical Research Program, which is a SBIR Phase III action with no set-aside designation. Critical Innovations LLC is an ISO certified, DCAA compliant medical R&D company that has received over $10...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Medical Command (MEDCOM) of the Defense Health Agency (DHA) to Critical Innovations LLC, a small business LLC. The $1,100,000.00 contract is for the development of the "RX-Shooter Wearable Wound Infection Treatment Device" under Topic DHA213-009. The award is designated as a total small business set-aside. Critical Innovations is an ISO 13485:2016 certified medical research and development company that...